e.g. Tata motors, Reliance MF, 500570

SMS Pharmaceuticals Ltd. - Research Center

532815 SMSPHARMA Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 782.75 709.26 522.05 519.87 563.18
Expenses
Material consumed 442.81 430.70 341.38 282.10 345.37
Manufacturing expenses 79.63 66.79 51.55 48.23 34.02
Personnel expenses 80.08 64.15 55.04 51.02 41.17
Selling expenses - - - - -
Adminstrative expenses 40.26 30.79 19.37 24.03 21.50
Expenses capitalised - - - - -
Cost of sales 642.77 592.42 467.35 405.39 442.07
Operating profit 139.97 116.84 54.70 114.48 121.11
Other recurring income 6.22 4.46 4.89 5.20 3.45
Adjusted PBDIT 146.20 121.30 59.59 119.68 124.56
Financial expenses 18.54 23.46 21.92 18.88 11.16
Depreciation 34.34 31.52 32.13 32.15 22.28
Other write offs - - - - -
Adjusted PBT 93.32 66.33 5.55 68.65 91.12
Tax charges 24.94 16.91 1.47 0.62 30.16
Adjusted PAT 68.38 49.42 4.08 68.04 60.96
Non recurring items -0.50 0.05 -0.21 0.04 -0.16
Other non cash adjustments - - - - -
Reported net profit 67.88 49.48 3.88 68.08 60.80
Earnigs before appropriation 426.91 371.70 324.76 333.42 275.35
Equity dividend 3.39 2.54 2.54 2.54 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 423.53 369.16 322.22 330.88 275.35
Close
Add SMS Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add SMS Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback